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Abstract – The interferon-induced Mx proteins of vertebrates are dynamin-like GTPases, some isoforms of
which can additionally inhibit the life cycle of certain RNA viruses. Here we show that the porcine Mx1
protein (poMx1) inhibits replication of inﬂuenza A virus and we attempt to identify the step at which the
viral life cycle is blocked. In infected cells expressing poMx1, the level of transcripts encoding the viral
nucleoprotein is signiﬁcantly lower than normal, even when secondary transcription is prevented by
exposure to cycloheximide. This reveals that a pretranscriptional block participates to the anti-inﬂuenza
activity. Binding and internalization of incoming virus particles are normal in the presence of poMx1 but
centripetal trafﬁc to the late endosomes is interrupted. Surprisingly but decisively, poMx1 signiﬁcantly
alters binding of early endosome autoantigen 1 to early endosomes and/or early endosome size and spatial
distribution. This is compatible with impairment of trafﬁc of the endocytic vesicles to the late endosomes.
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1. INTRODUCTION
Nearly 50 years ago, the inbred mouse strain
A2G was shown to be resistant to doses of
mouse-adapted inﬂuenza A virus that were
lethal to other inbred strains [15]. This innate
resistance to experimental infection with inﬂu-
enza A viruses behaved as a single autosomal
dominant trait [16]. Positional cloning of the
relevant locus later revealed that the phenotype
was encoded by a single gene on chromosome
16, coding for an approximately 75-kDa dyn-
amin-like protein with GTPase activity: the
Mx protein [29]. Close inspection of this gene
revealed a correlation between the susceptibility
of most inbred laboratory strains to orthomyx-
oviruses and either a premature stop codon or
a large deletion spanning exon 9 to exon 11,
both mutations leading to synthesis of a
truncated Mx1 protein [37]. It soon became
clear that the mouse Mx1 gene was only the
ﬁrst member of a small family of 1 to 3 genes
present in all vertebrates. In all cases studied
to date, expression of the Mx proteins is strictly
subordinated to the presence of interferon
IFNa/b. Only some isoforms exert antiviral
activity, which further depends on their subcel-
lular localization. Nuclear Mx proteins,
observed only in rodents, inhibit orthomyxovi-
ruses exclusively, whereas cytoplasmic Mx pro-
teins display as a group a very broad antiviral
spectrum suggestive of functional diversity. It
is important to discover the mechanisms under-
lying these various antiviral activities. Such
knowledge should open prospects of develop-
ing new antiviral drugs, which seems particu-
larly important in the ﬁeld of inﬂuenza A
viruses. To our knowledge, four Mx isoforms
capable of blocking the inﬂuenza A virus
life cycle have been undisputedly identiﬁed to
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the human MxA protein [26]. The only Mx
whoseanti-inﬂuenzaactionmechanismhasbeen
identiﬁed is the murine Mx1 protein, which
blocks primarytranscription of orthomyxovirus-
esviamolecularinteractionwiththePB2subunit
of the viral polymerase [12, 40]. In our opinion,
identifying the anti-inﬂuenza mechanisms of
human MxA and porcine Mx1 (poMx1) should
be a priority, because these proteins still inhibit
thelifecycleofinﬂuenzaAvirusafterthousands
of years of co-evolution. This suggests that the
innate resistance mechanisms involved could
be hard to fully bypass, even for a virus that is
known for its genetic plasticity. These two Mx
proteins localize to the cytoplasm, which pre-
vents them from interfering with transcription,
like murine Mx1. The only study to have
addressed this question concluded that there
must be a block downstream from primary tran-
scription. More precisely, the production of viral
transcripts, their polyadenylation, and their
export from the nucleus to the cytoplasm were
all intact in the presence of the human MxA
protein [27]. Here the aim was to contribute to
identifying the mechanism underlying the anti-
inﬂuenza activity of poMx1. Our results are
deﬁnitely compatible with the presence of a pre-
transcriptional block, which conﬁrms the func-
tional diversity of the Mx proteins.
2. MATERIALS AND METHODS
2.1. Generation of the Vero cell clone producing
poMx1 upon induction
The T-Rex technique (Invitrogen, Carlsbad, CA,
USA) was used to generate double-transgenic Vero
cell clonal lines showing tightly regulated conditional
expression of poMx1 upon exposure to doxycycline.
Vero cells (ATCC#CCL-81) grown at 37  Ci na5 %
CO2-air mixture in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal bovine serum,
1% (v/v) penicillin-streptomycin and 0.5% amphoter-
icin (DMEM/10) were ﬁrst transfected with the
expression plasmid pcDNA-TetR (Invitrogen) by
the lipofectamine 2 000 procedure according to the
manufacturer’s instructions. Vero cells were chosen
because their genetic defect in type I IFN production
prevents activation of endogenous type I IFN-depen-
dent effectors upon infection, thus allowing an arte-
fact-free functional evaluation of exogenous Mx
proteins [9]. Transfectants resistant to blasticidin
(10 lg/mL) were recovered after 2 weeks of selection
and cloned once by limiting dilution. Resulting
clones were obtained after an additional 4-week
round of blasticidin selection and screened for tightly
controlled conditional expression by measurement of
eGFP expression after transient transfection with our
expression plasmid pcDNA4-eGFP [3] and detection
by ﬂow cytometry. A few clones combined intense
ﬂuorescence in the presence of 1 lg/mL doxycycline
and total extinction without doxycycline. The trans-
fectin technique was then used to transfect one of
these clones (Vero/TetR1) with PvuI-linearized
pcDNA-poMx1a, our mammalian expression vector
for the alpha isoform of poMx1 [24]. Transfected
Vero/TetR1 cells were then seeded into DMEM/10
for 24 h without selection, after which blasticidin
(10 lg/mL) and zeocin (350 lg/mL) were added.
Blasticidin/zeocin-resistant double transfectants were
recovered after 4 weeks of selection and cloned by
limiting dilution.
The resulting clones were screened for poMx1
expression by combined immunoﬂuorescence and
immunoblotting. Immunoﬂuorescence was carried
out on induced (1 lg/mL) Vero/TetR1/poMx1 cell
clones grown on coverslips. Cells were ﬁxed with
4% (w/v) paraformaldehyde in phosphate-buffered
saline (PBS) for 30 min at 4  C, permeabilized in
PBS/saponin (0.2% w/v), blocked for 1 h in PBS/
saponin/BSA (1% w/v) at room temperature (RT),
probed for 1 h at RT with a rabbit antiserum raised
against human MxA (a kind gift from I. Julkunen,
Finland), and after three washings, incubated for a
further 1 h with relevant secondary antibodies conju-
gated to Alexa 488 (Molecular Probes, Merelbeke,
Belgium). Processed coverslips were then screened
with an Olympus BX51 epiﬂuorescence microscope.
For Western blot analysis, non-induced and induced
(1 lg/mL doxycycline) Vero/TetR1/poMx1 cell mon-
olayers were washed three times in PBS and har-
vested by trypsinization. Cell pellets were boiled
for 5 min in loading buffer and aliquots were electro-
phoresed on a 4–12% SDS-polyacrylamide gel
(Invitrogen). Proteins were then transferred onto a
polyvinylidene diﬂuoride membrane (Amersham
Bioscience, Diegem, Belgium), and nonspeciﬁc bind-
ing blocked with 1% Western Blocking Reagent
(Roche Bioscience, Vilvoorde, Belgium) at 4  C
overnight. Blocked membranes were probed with
the anti-MxA rabbit antiserum diluted 1:1000 and
with an anti-b-actin mAb in Tris-buffered saline
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at 37  C for 60 min. The membrane was then
washed in TBS/Tween 20 (0.1% w/v) and incubated
further with HRP-conjugated goat anti-rabbit and
anti-mouse IgG (Cell Signaling Technology, Leiden,
The Netherlands) at 37  C for 60 min. Blots were
then washed sequentially in PBS and distilled water
and developed by incubation with 3-amino-9-ethylc-
arbazole (Dakocytomation, Heverlee, Belgium).
2.2. Viruses, infections, and virus-yield
reduction assays
Two inﬂuenza A viruses, a porcine H1N1 virus
(A/swine/Iowa/4/1976), and a H3N2 reassortant
(X31) with the glycoproteins from A/Aichi/2/68
and the rest of the genes from the human mouse/
egg-adapted A/PR/8/34 strain, were used in this study.
The two viruses were propagated and stocks were
produced and plaque-titered on Vero cells. For infec-
tions, stock aliquots were ﬁrst diluted in DMEM
supplemented with 0.2% BSA (Invitrogen) and
2 lg/mL trypsin-TPCK (Sigma-Aldrich, Bornem,
Belgium). Serial dilutions were prepared just before
use in order to generate volume-matched inoculums
with appropriate multiplicities of infection. When
the endocytic entry of inﬂuenza A viruses was tar-
geted, a very high multiplicity of infection was used
(> 150) to allow detection of incoming particles, as
previously shown [8, 34]. Upon infection, viruses
w e r ea l l o w e dt oa d s o r bf o r6 0m i na t3 7 Ca n dt h e n
cell monolayers were thoroughly washed and incu-
bated further with fresh DMEM/10. Infections were
stopped, after predeﬁned time intervals depending
on the step of the viral cycle targeted, by incubation
in 4% (w/v) paraformaldehyde in PBS for 30 min at
4  C. Interference of poMx1 expression with the bio-
logical cycle of inﬂuenza A viruses was probed by
ﬂow cytometric detection of nucleoprotein (NP) syn-
thesis in transiently transfected Vero cells and virus-
yield reduction assays performed on induced and
non-induced V50 cells. Transfection was performed
according to the Transfectin technology (BioRad
Laboratories, Nazareth, Belgium), essentially as
described by the manufacturer, using a transfection
mixture consisting of 50 lLM E M ,1lL Transfectin
and 50 lL MEM to which 0.75 lgo fe a c hp l a s m i d
DNA had been incorporated (pcDNA4-eGFP as neg-
ative control, pcDNA4-huMXA as positive control
and pcDNA4-poMX1a as experimental group).
Brieﬂy, Vero cells were seeded in 24-well plates
and grown overnight to 70–80% conﬂuency. Then,
cells were washed three times with PBS, medium
was replaced with 200 lL MEM per well, and
100 lL of the transfection mixture was slowly incor-
p o r a t e di ne a c hw e l l .T w e n t y - f o u rh o u r sa f t e rt r a n s -
fection, the cells were thouroughly washed three
times with PBS and the infectious mixture was incor-
porated in each well, the target multiplicity of infec-
tion being   1. After a 60-min inoculum-cell contact
for adsorption, the inoculum was removed by thor-
o u g hw a s h i n gw i t hP B Sa n dt h ec u l t u r e sw e r ei n c u -
bated at 37  C for 5 h in DMEM/2. Vero cells were
then harvested by trypsinisation and pelleted at 300 g
for 15 min. The cells were ﬁxed with 4% (w/v) para-
formaldehyde in PBS for 30 min at 4  C, permeabi-
lized in PBS to which 0.2% (w/v) saponin had been
added and blocked for 1 h in PBS, 0.2% saponin and
1% (w/v) BSA at RT. Cells were then incubated for
45 min with a cocktail of primary antibodies, i.e.
the polyclonal rabbit anti-huMxA antiserum and a
monoclonal anti-NP antibody (Abcam, Belgium) at
37  C. After three washing steps, the cells were incu-
bated with the relevant Alexa 467- (NP) or 488-
conjugated (Mx) secondary antibodies (Molecular
Probes) at 37  C. The immunolabelled cells were
ﬁnally resuspended in PBS and analysed with the
BD-Canto ﬂow cytometer, gating on the forward
and side scatter to exclude debris and collecting
ﬂuorescences in FL-1 and FL-5. A minimum of
10
4 events were acquired and analysed with the BDF-
ACSDiva software v4.1.1.
For virus yield reduction assays in V50 cell mon-
olayers, the infected cultures were incubated at 37  C
for 48 h in DMEM/2. The culture supernatants were
sampled and viral titers determined in triplicate by
standard median tissue culture infectious dose assays.
2.3. Quantiﬁcation of transcripts encoding
inﬂuenza A virus NP
Three hours after a standardized infection (H1N1,
m.o.i. = 1), inﬂuenza A virus NP transcript levels
were compared in monolayers of induced and non-
induced V50 cells exposed or not to cycloheximide
(100 lg/mL).
2.3.1. Production of cDNA samples
Infected V50 cell monolayers were individually
homogenized (Qiagen’s TissueLyser, 30 Hz for
5 min, Venlo, The Netherlands) in TRIzol (Invitro-
gen) for preparation of total mRNA. Each homoge-
nate was treated with TURBO DNase (Ambion,
Lennik, Belgium) for 30 min at 37  C. After puriﬁ-
cation by use of the Invisorb Spin Cell RNA Minikit
50 according to the manufacturer’s instructions (Invi-
tek, Berlin, Germany), the purity and concentration
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cally (the OD260/280 and OD260/230, respectively,
were in the ranges 1.9 ! 2.0 and 1.8 ! 2.2, Nano-
Drop-1000/Isogen) and mRNA integrity was checked
by agarose gel electrophoresis. An aliquot of each
condition-speciﬁc total RNA extract (2 lg RNA)
was then reverse-transcribed at 42  Cf o r6 0m i ni n
t h ep r e s e n c eo f2lL oligo-DTs (10 lM) and the
ImProm II
TM reverse transcription system (Promega,
Leiden, The Netherlands).
2.3.2. Real-time PCR
The primer pairs used to amplify fragments of the
viral NP transcripts and the probe used to detect the
ampliﬁed fragments were as follows: 50-ATCCTG
GAATGCTGAAT-30 (fwd), 50-ACCAAACGAAA
ATCCAGC-30 (rev), and 50-GCTCATAAGTCTTGC
CTGCTTGTGTG-30 (FAM-TAMRA). The PCR
mixture consisted of template cDNA (1 lL),
100 nM primers (0.5 lL of each), 100 nM probe
(0.5 lL), and 47.5 lL1· ABsolute
TM QPCR ROX
Mix (AB Gene, Leusden, The Netherlands) in a ﬁnal
volume of 50 lL. The mixture was placed in an ABI
PRISM
  7700HT thermocycler and ampliﬁcation
was carried out under the following conditions: ini-
tial denaturation at 95  C for 15 min, followed by
40 cycles of denaturation at 95  C for 15 s and
annealing-extension at 57  Cf o r6 0s ,a n dt h e na
ﬁnal extension at 72  C for 30 s. Ampliﬁcation of
transcripts was performed in triplicate, and three
independent sessions were carried out with each
RNA extract. The melting curve of each amplicon
was monitored by means of a swing back to 50  C,
followed by a stepwise rise in temperature up to
95  C. Melting curve analysis always revealed the
presence of a single product. To check for false pos-
itives, RT-free and no-template controls were run for
each template. Amounts of NP-encoding mRNA
were normalized with respect to the amount of
endogenous 18S ribosomal RNA, which was deter-
m i n e db yu s eo ft h eT a q M a n
  Ribosomal RNA Con-
trol Reagents kit (Applied Biosystems, Foster City,
CA, USA).
2.4. Staining of virus proteins and host
endosomes
2.4.1. Indirect immunoﬂuorescence assays
Monoclonal antibodies raised against NP and pH-
dependent speciﬁc conformations of HAwere used to
detect inﬂuenza A viruses, whereas a mAb targeting
the early endosome autoantigen 1 (EEA1) protein
was used to visualize earlyendosomes.Semiconﬂuent
induced and non-induced V50 cells on coverslips
were infected with the H1N1 or H3N2 inﬂuenza
A virus. At predeﬁned time points after infection,
the cells were ﬁxed with 4% (w/v) paraformaldehyde
in PBS for 30 min at 4  C, permeabilized as
described above, and immunostained by sequential
incubation with anti-NP mAb (Abcam), anti-HA
m A bN 2o rA 2( ak i n dg i f tf r o mJ . - M .W i t h ,U n i v e r -
sity of California, USA) or anti-EEA1 mAb (Abcam),
and then with AlexaFluor 488-conjugated goat anti-
mouse IgG secondary antibodies (Molecular Probes).
The immunolabeled cells were visualized with a laser
scanning confocal microscope (Olympus).
2.4.2. Visualization of endocytosed membranes
For monitoring the fate of primary endocytic ves-
icles, V50 cell plasma membranes and virus enve-
lopes were saturated with the lipophilic ﬂuorescent
dye DiD (1,10-dioctadecyl-3,3,30,30-tetramethylind-
oldicarbocyanine, 4-chloro-benzenesulfonate salt,
Molecular Probes) by incorporating the dye 20 min
before adsorption of the virus. In this case, the cells
were visualized directly after ﬁxation.
3. RESULTS
3.1. Conditional expression of poMx1
in Vero cells
We sought to obtain Vero cells that would
express poMx1 conditionally, in response to
the presence of doxycycline in the medium.
A series of 264 blasticidin/zeocin-resistant dou-
ble-transgenic clones was screened. Immuno-
ﬂuorescence staining was used to determine,
for each clone, (i) the proportion of cells
expressing poMx1 when grown in doxycy-
cline-free medium, (ii) the proportion of
cells expressing poMx1 upon induction, and
(iii) the subcellular intensity of poMx1 staining.
Only one clone (hereafter referred to as V50)
combined less than 5% spontaneous expression
with more than 95% expression and intense
cytoplasmic granular staining upon exposure
to doxycycline. The clone was characterized
further by Western blotting, which conﬁrmed
synthesis of an approximately 74-kDa protein
recognized by human-MxA-speciﬁc antiserum
(Fig. 1). The pattern of poMx1 expression
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passaging every 3–5 days as needed. Sequenc-
ing of the product ampliﬁed from induced V50
extracts by poMx1-speciﬁc RT-PCR yielded the
authentic poMx1 CDS.
3.2. Inﬂuenza A virus NP synthesis and
infectious particle production are blocked
upon poMx1 expression
Virus NP synthesis from infections of Vero
cells that had been transiently transfected by
plasmids encoding either eGFP (negative con-
trol), huMxA (positive control), or poMx1
was assayed, and the results are shown in
Figure 2 (A–B). Given the reproducibility of
the infection rate among nonexpressing cells
between experiments (white boxes in
Fig. 2B), whatever the plasmid tentatively
incorporated was, we assume that the transfec-
tion procedure itself equally affected the cell
populations transfected/infected. Moreover, as
the infection rate of eGFP-expressing cells
tended to be higher than that of nonexpressing
Figure 1. Expression of poMx1 in double-transgenic Vero cells examined by ﬂuorescence microscopy and
immunoblotting (clone V50). Transgenic cells were induced with 1 lg/mL doxycycline for 24 h. Induced
mono-transgenic cells (clone Vero Tet/R1) are presented for control purposes (low background and absence
of cross-reactivity with endogenous Cercopithecus aethiops Mx). Clone V50 combined less than 5%
spontaneous expression with more than 95% expression and intense cytoplasmic granular staining upon
exposure to doxycycline. The Western blot reveals a speciﬁc band in the lane for induced cells. The
molecular mass corresponding to this band is compatible with that of poMx1 (74 kDa). For indirect
immunoﬂuorescence (A), cells were permeabilized and stained by sequential incubation with a rabbit
antiserum raised against human MxA (a gift from I. Julkunen, Helsinki, Finland), which had been shown to
cross-react with porcine Mx1 [24], and with Alexa 488-conjugated goat anti-rabbit IgG. (B) Immunoblots of
4–12% sodium dodecyl sulfate polyacrylamide gels with total cell proteins extracted from induced (dox +)
and non-induced ( ) V50 cells (10 lg total protein per lane, as determined by a micro-BCA assay).
Immunostaining was done by sequential incubation with a cocktail of the above-mentioned rabbit antiserum
and anti-b-actin mAb and a mix of HRP-conjugated anti-rabbit and anti-mouse IgG. Blots were developed
by incubation with 3-amino-9-ethylcarbazole. The positions of protein size markers in kilodaltons are
indicated (MW). (A color version of this ﬁgure is available on line at www.vetres.org.)
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per se did not alter the virus biological cycle in
the cell preparations studied (Fig. 2B). The sys-
tematic depletion (p < 0.01) of NP-positive
cells among MX-expressing cell populations
(black boxes in Fig. 2B) is therefore attributable
to the Mx proteins themselves.
Furthermore, viral yields from infections of
non-induced and induced stably transduced
V50 cells were assayed, and the results are
Figure 2. Porcine Mx1 expression alters inﬂuenzavirus NP synthesis (A–B) and production of infectious
progeny particles (C). A–B: ﬂow cytometric determination of NP-positive counts in Vero cells transfected
with plasmids (pcDNA4) encoding either eGFP (negative control), porcine Mx1 (poMx1a) or human MxA
(huMxA, positive control). (A) Example. Cell counts (vertical axis) refer to infected (NP-positive) and
noninfected (NP-negative) cells detected in induced (transgene-expressing, dark grey) and non-induced
(nonexpressing, light grey) cell populations. (B) Percent NP-positive cells 5 hpi in transgene-expressing
(black boxes) and nonexpressing (white) cells. The corresponding plasmids had been transfected 24 h
before infection, each population process resulting in a mixed population of expressing and nonexpressing
cells. Cells were permeabilized, double immunostained for Mx proteins and virus NP and analysed using the
FACS Canto, gating on the forward and side scatter to exclude debris and collecting ﬂuorescences in FL-1
and FL-5. A minimum of 10 000 events were acquired and analyzed with BDFACSDiva software v4.1.1.
Each box pair (white/black) represents means ± SD in nonexpressing/expressing cells from 3 independent
experiments. Expression of both porcine and human MxA resulted in a signiﬁcant decrease of NP-positive
cell counts at the timepoint studied (5 hpi). (C) Inﬂuenza virus yields from stably-transduced porcine Mx1-
expressing Vero cell monolayers were signiﬁcantly decreased after induction of poMx1 expression. Pools of
induced (black boxes) and non-induced (white boxes) V50 cells were infected with the H1N1 virus for 48 h
(m.o.i. = 0.01). The viral titers in the culture supernatants are plotted, as determined in triplicate by standard
median tissue culture infectious dose assays. TCID50: 50% tissue culture infective dose. Plotted values
are means ± SD of 3 independent experiments. *Signiﬁcantly different from the titer retrieved from the
corresponding non-induced cells, p < 0.05. (A color version of this ﬁgure is available on line at
www.vetres.org.)
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caused a signiﬁcant (  10 times) reduction in
virus infectious particle yields. No titer reduc-
tion was observed when Vero/TetR1 cells were
infected, with or without addition of doxycy-
cline (data not shown), suggesting that the
resistance conferred is attributable to poMx1
expression.
3.3. Upon poMx1 expression, viral protein
production is blocked before early
translation
For the ﬁrst 9 h after infection, synthesis of
the viral NP was monitored by immunoﬂuores-
cence in V50 cells induced or not with doxycy-
cline (Fig. 3). Non-induced cells followed a
very reproducible scenario: at 4 h post-infection
(pi), a weak but undeniable NP-speciﬁc signal
was perceptible in a very small minority of
the nuclei; at 5 hpi, between a third and a half
of the nuclei showed intense, homogeneous
staining, with only the nucleoles remaining NP-
negative. At 6 hpi, 90% of the nuclei were NP-
positive and NP had begun to spread to the
cytoplasm. In all cells showing a cytoplasmic
signal, the nuclei showed a ‘‘centrifugal’’ stain-
ing pattern, with an NP-negative center and a
conspicuously NP-positive nucleoplasmic mar-
gin. After 7 hpi, most cells showed intense
cytoplasmic labeling, and some nuclei had
become NP-negative. Doxycycline-induced
V50 cells, on the other hand, showed delayed
and much lower NP synthesis as compared to
non-induced cells (Fig. 3). We conclude that
the mechanism (or one of the mechanisms) by
which poMx1 inhibits inﬂuenza A viruses
enters in action before or during translation of
NP transcripts.
3.4. Upon poMx1 expression, viral mRNA
production is blocked before primary
transcription
To see if poMx1 affects translation of viral
mRNA, we measured the level of NP tran-
scripts available for translation. For this we per-
formed reverse-transcription real-time PCR on
extracts of infected V50 sampled 3 hpi. After
optimization, the ampliﬁcation efﬁciency
remained constant over a range spanning 5
orders of magnitude for both 18S (R
2 =
0.9207) and NP (R
2 = 0.947) RNA transcripts.
As compared to their poMx1-nonexpressing
counterparts, poMx1-expressing cells showed
an approximate 65% decrease in the level of
NP-encoding transcripts available for transla-
tion (Fig. 4). As the ﬁnal NP transcript level
is the result of both primary transcription (of
the initial parental genomes) and secondary
transcription (of progeny vRNP), we repeated
the experiment in the presence of cyclohexi-
mide to see if the block occurs before or after
primary transcription. In the presence of cyclo-
heximide, poMx1 expression still caused a
strong decrease (  40%) in the NP transcript
level (Fig. 4). We conclude that poMx1 inhibits
the inﬂuenza A virus cycle before primary
transcription.
3.5. Generation of virion-containing late
endosomes is inhibited/delayed upon
poMx1 expression
To see if poMx1 exerts its inhibitory effect
on parental vRNP injection into the cytoplasm
from the late endosomes or on the translocation
of these vRNP from the cytoplasm to the
nucleus, we examined whether poMx1 can alter
the post-infection perinuclear accumulation of
late endosomes. For this we speciﬁcally labeled
the cell membranes by incubating the cells in
DiD, a lipophilic dye. Each time non-induced
V50 cells were processed in this manner and
then infected for 40 min, the same pattern of
intense perinuclear staining was observed, sug-
gesting the occurrence of massive endocytosis
followed by centripetal trafﬁcking and perinu-
clear accumulation of membranes and endocy-
tosed virions (Fig. 5). In contrast, induced
V50 cells showed much weaker to no perinu-
clear staining. This suggests that poMx1 blocks
or delays an event preceding perinuclear accu-
mulation of particles internalized into late endo-
somes (Fig. 5).
After internalization, inﬂuenza A virions are
transferred ﬁrst to early endosomes, then to late
endosomes, where acidiﬁcation leads to an irre-
versible conformational change in the viral
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expression. Production of viral NP by induced and non-induced V50 cells was monitored for 9 h after
infection by indirect immunoﬂuorescence, after sequential incubation with the anti-NP mAb from Abcam
and Alexa 488-conjugated goat anti-mouse IgG. See text for detailed comparative analysis of NP production
scenario in induced and non-induced cells.
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delayed transport from primary endocytic vesi-
cles into late endosomes should result in dimin-
ished or delayed adoption of the ‘‘acidic’’
conformation of inﬂuenza A virus HA. When
non-induced V50 cells were immunostained
40 min pi with the conformation-speciﬁc mAb
A2 speciﬁcally targeting acidic HA, a bright
perinuclear signal was observed, as expected
(Fig. 6). Similarly immunostained induced
V50 cells showed only a faint, if any, signal.
Taken together, these two experiments show
that accumulation of incoming virions in peri-
nuclear late endosomes is inhibited or delayed
by poMx1.
3.6. Generation of virion-containing primary
endocytic vesicles is not affected by poMx1
To see whether poMx1 hinders binding and
internalization of incoming virions, the above
experiment was repeated except that infection
was stopped only 10 min pi and that the cells
were immunostained with the conformation-
speciﬁc mAb N2, which speciﬁcally targets
the ‘‘neutral’’ conformation of HA. In this case
the HA immunoﬂuorescence signature was
identical whether the cells were exposed to
doxycycline or not, with preferential labeling
of the cell periphery (Fig. 6).
3.7. The size, number, and spatial distribution
of EEA1-positive subcellular structures are
altered upon poMx1 expression
Early endosome autoantigen 1 binds to
phosphatidylinositol-3,4,5-triphosphate (PIP3)
and localizes, together with Rab5, to primary
endocytic vesicles and early endosomes at the
cell periphery. It is thus a good marker of the
integrity of the early segment of the endocytic
pathway. Immunostaining of EEA1 in non-
induced V50 cells reproducibly revealed a ﬁnite
number of distinct, bright spots, whereas stain-
ing was always weak and diffusely distributed
in doxycycline-induced cells (Fig. 7).
4. DISCUSSION
Pig cells express two different Mx proteins,
poMx1 and poMx2, upon IFN-a treatment
[20]. We have demonstrated that poMx1
decreases or delays NP synthesis, and inhibits
production of progeny viral particles. Among
the various blocks theoretically possible, we
have shown that poMx1 already hampers viral
infection at an early stage and we attempted
to identify the limiting early step. Speciﬁc trans-
port processes provide excellent targets for
interference with inﬂuenza virus life cycle
[31]. Here we present evidence that poMx1
blocks the normal centripetal movement of
incoming viral particles into the nucleus by
interfering with an early step of the endocytic
pathway: it would appear to alter either the
Figure 4. Porcine Mx1 blocks the inﬂuenza A
virus life cycle before primary transcription. Cell
monolayers were infected with the H1N1 inﬂuenza
A virus strain for 3 h. Production of transcripts
encoding H1N1 inﬂuenza A virus NP was quanti-
tated by reverse transcription and real-time PCR in
induced and non-induced V50 cells exposed or not,
as indicated, to the translation inhibitor cyclohex-
imide (CHX, 100 lg/mL). 18S rRNA was used as
an internal control to normalize NP transcript data,
and results were expressed percentages of the
amount of NP transcripts retrieved from non-
induced and nonexposed V50 cells, i.e. the only
cells in which the virus life cycle proceeds
unhindered. In the absence of CHX, poMx1
expression caused an approximately 65% reduction
of NP-encoding mRNA production, and an approx-
imately 40% reduction was still observable after
exposure to CHX. Plotted values are means ± SD
of triplicate real-time PCR assays, and three
independent experiments were performed, with
similar results. Fisher’s exact test was used to
compare the means and the reported signiﬁcance
levels are p < 0.05 (*) and p < 0.01 (**). AU:
arbitrary units. See text for detailed interpretation.
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somes or the number, morphology, and spatial
distribution of early endosomes. We base this
conclusion on the results of several successive
experiments.
Firstly, as poMx1 is cytoplasmic and as the
synthesis of both NP protein and NP transcripts
is strongly inhibited in the presence of poMx1,
the viral cycle must be hindered either before
transcription or between primary and secondary
transcription. Use of the translation-inhibiting
agent cycloheximide has enabled us to show
that a blockade occurs upstream from transcrip-
tion. When inﬂuenza-A-virus-infected cells are
exposed to cycloheximide, the absence of de
novo synthesis of the viral proteins NP, PB1,
PB2, and PA prevents polymerization of the
negative progeny-genome RNA strands from
cRNA strands [4, 41, 43]. Hence, by comparing
the NP transcript levels observed in the pres-
ence and absence of cycloheximide, it is possi-
ble to distinguish a pretranscriptional block
(which should affect the levels of transcripts
resulting from transcription of both parental
and neosynthesized matrices) from an intratran-
scriptional block (which should affect only
those resulting from transcription of neosynthe-
sized matrices). Our results reveal unambigu-
ously that in the presence of poMx1, the viral
cycle is already inhibited before primary tran-
scription, thus before injection of vRNP into
the nucleus. As the only available study to have
addressed the anti-inﬂuenza mechanism of a
cytoplasmic Mx protein, human MxA, led to
the conclusion that the virus cycle is blocked
after primary transcription [27, 44], the present
results highlight the functional diversity among
mammalian Mx proteins.
Before becoming available for primary tran-
scription in the nucleus, parental vRNP undergo
Figure 5. Porcine Mx1 expression inhibits the centripetal trafﬁc of endocytic vesicles containing incoming
inﬂuenza A virus particles. Twenty minutes after addition of the lipophilic dye DiD to the medium, an
inoculum drawn from the H1N1 inﬂuenza A virus stock and corresponding to a multiplicity of infection
of   200 was added to induced and non-induced V50 cells. Infection was stopped 40 min after infection by
thorough PBS washings and ﬁxation of cell monolayers with 4% paraformaldehyde. No additional staining
was done, so the only visible ﬂuorescence signals are from endocytosed fragments of plasma membrane and
viral particles. Forty minutes after infection, non-induced cells displayed endocytosed material concentrated
around the cell nuclei. Induced cells, in contrast, reproducibly displayed a diffuse, punctate, ‘‘dusty’’ pattern
compatible with a block in the normal centripetal trafﬁc of endocytosed materials.
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(i) binding and (ii) receptor-mediated endocy-
tosis of the viral particle, (iii) docking and
fusion of primary endocytic vesicles and early
endosomes, (iv) early endosome fragmentation
and generation of endosomal carrier vesicles,
(v) movement towards and fusion with late
endosomes, (vi) acidiﬁcation-dependent fusion
of viral and late endosomal membranes and
subsequent delivery of the virus genome to
Figure 6. The trafﬁc of incoming viral particles is blocked by poMx1 after internalization but before the
acidiﬁcation-induced conformational change of viral hemagglutinin in the late endosomes. Induced and
non-induced cell monolayers were infected with a dilution of the H3N2 inﬂuenza A virus stock
(m.o.i.   200) and examined 10 min (upper half) and 40 min (lower half) pi after immunostaining of
poMx1 (in red) or viral HA (in green). Ten minutes pi, internalized viral particles were detected by labeling
the neutral form of the viral HA with N2 mAb. The results are similar for induced and non-induced cells.
Forty minutes pi, internalized virus particles having arrived in the perinuclear region were detected by
labeling the acidic HA form, this time with the A2 mAb. Non-induced cells show conspicuous staining of
acidic HA in the perinuclear region, but induced cells do not. In the latter, trafﬁc to the late endosomes is
thus delayed. (A color version of this ﬁgure is available on line at www.vetres.org.)
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into the nucleus [1, 10, 11, 14, 17, 18]. To iden-
tify the limiting step of this centripetal trafﬁc in
the presence of poMx1, we have used two inde-
pendent approaches, both aiming to establish
whether the virus cycle takes place as usual
from the time the infecting viruses bind to the
cell until the viral particles reach the late endo-
somes. The design of these experiments is
inspired from the results of other teams, show-
ing that by 40 min pi, the great majority of
incoming viral particles have colocalized with
late endosomal markers in close proximity to
the cell nucleus [33]. In our ﬁrst experiment,
both induced and non-induced V50 cells were
exposed to a lipophilic ﬂuorescent dye, DiD,
shortly before infection. Under these condi-
tions, perinuclear ﬂuorescent label was detected
40 min pi in the absence of poMx1, but not in
the poMx1-expressing cells. As plasma mem-
branes are intrinsically impermeable to DiD,
the ﬂuorescent spots observed in the cytoplasm
must necessarily reﬂect the presence of mem-
brane fragments internalized by endocytosis
during concomitant exposure of the cells to
both DiD and the virus. Hence, the diffuse
DiD retention observed at the cell periphery
in the presence of poMx1 suggests blocking
of the centripetal trafﬁc of primary endocytic
vesicles to the perinuclar late endosomes. The
second battery of experiments imagined to
examine the centripetal trafﬁc of incoming viral
particles consisted in examining whether the
shift of viral hemagglutinin to its acidic confor-
mation is inﬂuenced by the presence of poMx1.
To carry out this experiment, we took advan-
tage of the mAb A2 known to target speciﬁcally
the acidic conformation (adopted below pH 6.0)
of hemagglutinin H3 of strain X-31 [33, 38].
Once again, striking differences appeared
between non-induced and poMx1-expressing
V50 cells: in the former, many bright aggluti-
nated spots were seen in close proximity to
the nucleus, whereas the latter cells showed
no signiﬁcant labeling. Since in the course of
their normal cycle virions are exposed to a
gradually decreasing pH, occurring when they
are transferred from the early to the late endo-
somes and responsible for the conformational
change of hemagglutinin, we conclude that in
the presence of poMx1, the hemagglutinins of
the incoming virions have not yet adopted their
acidic conformation at a time when those of
non-induced cells already have. Taken together,
these two experiments demonstrate that the cen-
tripetal trafﬁc of primary endocytic vesicles and
their content is slowed down in the presence of
poMx1. In particular, perinuclear agglutination
of incoming virions does not occur within the
standard time span (40 min). We then examined
whether induced and non-induced cells might
differ as regards binding and/or internaliza-
tion of infecting virions. This time we used
mAb N2, known to recognize speciﬁcally
the ‘‘neutral’’ conformation (adopted above
pH 6.0) of viral hemagglutinin [33, 38].
Figure 7. Porcine Mx1 expression alters the spatial distribution of structures bearing the early endosome
autoantigen 1 (EEA1). Early endosomes were immunostained by sequential incubation with a mAb
targeting EEA1 and with an Alexa 488-conjugated goat anti-mouse IgG. Numerous distinct bright granules
are visible in non-induced cells, corresponding to early endosomes. Only a diffuse, ‘‘dusty’’ pattern is seen
when poMx1 is expressed.
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whether the V50 cells were induced or not,
infecting virions were observed at the cell
periphery 10 min pi, as observed by others
[33]. The poMx1 protein thus does not affect
binding and internalization of incoming virions,
as observed previously for human MxA [32].
Now that it appears established that poMx1
blocks the viral life cycle after internalization
but before acidiﬁcation in the late endosomes,
we can suspect hindering of (i) docking and
fusion of virus-containing primary endocytic
vesicles and early endosomes, (ii) the trafﬁc
of the endosome transport carrier vesicles that
fragment off from the early endosome and
translocate towards the cell center, or (iii) coa-
lescence of endosome transport carrier vesicles
with late endosomes [5, 23, 28, 42]. As early
endosomes constitute the ﬁrst sorting station
on which many routes of endocytosis converge
[19] and because inﬂuenza-A-virus-containing
primary endocytic vesicles translocate to them
[33], we then gave priority to examining this
step. Docking of primary endocytic vesicles to
early endosomes and their fusion with them
are regulated mainly by the GTP-bound Rab5
on the donor membrane and PIP3 on the accep-
tor membrane. These molecules then function
as a ‘‘coincidence’’ signal for recruitment of
the cytoplasmic protein EEA1, which cross-
links the two membranes [6, 25, 35, 39]. We
therefore examined the topological distribution
of EEA1-positive subcellular structures upon
poMx1 expression. As described in the litera-
ture [30], we identiﬁed many EEA1-positive
spots at the periphery of non-induced V50 cells.
In the presence of poMx1, this typical pattern
was abolished. One possible interpretation is
that poMx1 interferes with the action of
EEA1, which is indispensable to docking, to
fusion of virion-containing primary endocytic
vesicles to early endosomes, and to their motil-
ity along microtubules [28]. This would block
at least partially a key step in the centripetal
trafﬁc of incoming viral particles. How, exactly,
poMx1 could prevent normal association of
EEA1 with primary endocytic vesicles and
early endosomes at the molecular level remains
to be determined. Imaginably, mono- or multi-
meric poMx1 might wrap around one or both
of EEA10s‘ ‘ r e c e p t o r s ’ ’ ,G T P - b o u n dR a b 5a n d
PIP3, preventing local accumulation of EEA1
and dramatically inhibiting its ability to tether
primary endocytic vesicles to early endosomes.
Alternatively, poMx1 might cause depletion of
either Rab5-GTP or PIP3. If so, and if the afﬁn-
ity of EEA1 for either of these components is
low or if at least one of them is labile, EEA1
binding to membranes could be inefﬁcient.
Another interpretation compatible with the
observed ﬂuorescence pattern is that the early
endosomes undergo spatial redistribution and
a reduction in size. It is noteworthy in this
regard that exposure of MDCK cells to noco-
dazole, a microtubule-depolymerizing agent,
generates exactly the same changes in the
EEA1 staining pattern as observed here in
poMx1-expressing Vero cells [7]. The poMx1
protein might thus exert a nocodazole-like
effect, for instance by disorganizing the micro-
tubule networks, which would delay the
centripetal migration/maturation of carrier en-
dosomes containing incoming viral particles.
The credibility of this hypothesis is reinforced
by the recent demonstration by immunoprecip-
itation of the existence of close molecular inter-
actions between the human MxA protein and
tubulin [21]. It is noteworthy that 1 h after
infection of poMx1-expressing cells, a speciﬁc
immunostaining pattern was observed, consist-
ing of bright spots lining the plasma membrane,
accentuating the ‘‘tiled’’ aspect of the cell prep-
arations (Fig. 3). Interestingly, this pattern is
compatible with ‘‘stagnation’’ of recently inter-
nalized virus-containing endocytic vesicles at
the cell periphery. It resembles surprisingly
the typical images obtained after high-dose
inﬂuenza virus infection when endocytosis is
blocked with wortmannin [8, 13], a PI3K inhib-
itor blocking PIP3 synthesis and thereby abol-
ishing EEA1 binding. In any case, the present
results reveal a type-I-IFN-triggered antiviral
activity that aborts viral infection at an early
stage of infection. Because it prevents early
viral gene expression and genome replication,
preventing proper intracellular transport may
Pig Mx1 blocks trafﬁc of inﬂuenza particles Vet. Res. (2010) 41:29
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others to the rapid emergence of resistant virus
variants.
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